Holen Sie sich die Stockscreener-App
7.76
0.89%
-0.07
Handel nachbörslich:
7.58
-0.18
-2.32%
Kamada Ltd Aktie (KMDA) Neueste Nachrichten
Kamada Ltd (KMDA-Q) Stock Price and News - The Globe and Mail
Kamada stock launches two biosimilars as portfolio reaches four - AD HOC NEWS
Stifel reiterates Kamada stock Buy rating on biosimilar expansion By Investing.com - Investing.com Nigeria
Two drug launches in Israel expand Kamada (KMDA)'s portfolio as it projects sales through 2030. - Stock Titan
About $20 million to $25 million a year is what Kamada expects its medicines to bring in by 2030. - Stock Titan
No pre-approval inventory costs were booked as assets in 2024–25, Kamada (KMDA) says. - Stock Titan
Significant Move: Ishay Davidi Invests $152K In Kamada Stock Options - Benzinga
Witness A Substantial Acquisition As Uri Botzer Acquires $138K In Kamada Stock Options - Benzinga
Lilach Asher Topilsky At Kamada Secures Company Stock Options: $166K Acquired - Benzinga
Significant Move: Ishay Davidi Invests $162K In Kamada Stock Options - Benzinga
Director At Kamada Acquires Company Stock Options Worth $162K - Benzinga
Strategic Investment: Uri Botzer Boosts Portfolio With $148K In Kamada Stock Options - Benzinga
A special cash dividend prompted option-price adjustments for a Kamada (KMDA) director. - Stock Titan
Kamada (KMDA) director Ishay Davidi's previously reported options carry three adjusted exercise prices. - Stock Titan
A special cash dividend adjusted the exercise prices on Kamada (KMDA) director Uri Botzer’s options. - Stock Titan
Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth - Yahoo Finance
Kamada Targets $205M Revenue as Plasma Therapies, Kedrab Demand Fuel Growth - TradingView
Form 4 KAMADA LTD For: 27 September By Investing.com - Investing.com Nigeria
Form 4 KAMADA LTD For: 26 September By Investing.com - Investing.com Nigeria
Big News: Lilach Payorski Adds $136K In Kamada Stock Options Io Portfolio - Benzinga
Insider Decision Making Waves At Kamada: Boris Gorelik Exercises Options, Realizing $0 - Benzinga
Amir London Makes Strategic Play: Invests $1.80M In Kamada Stock Options - Benzinga
Form 4 KAMADA LTD For: 25 September By Investing.com - Investing.com Canada
A special dividend changed the exercise prices on two stock-option awards for Kamada (KMDA)'s CEO. - Stock Titan
KAMADA LTD (NASDAQ: KMDA) Grants 86,500 Derivative Securities to Director Goldwasser Karnit - Kalkine Media
A dividend changed the exercise prices on options acquired by a Kamada (KMDA) director. - Stock Titan
Kamada (KMDA) HR VP receives two option awards that vest in four annual installments. - Stock Titan
Strategic Move: Eran Nir Acquires Kamada Stock Options Worth $173K - Benzinga
Leon Recanati Seizes Opportunity: Acquires $154K Worth Of Kamada Stock Options - Benzinga
Nir Livneh Executes Major Move: Acquires $171K In Kamada Stock Options - Benzinga
A special cash dividend led Kamada (KMDA) to adjust a VP’s stock option prices to $5.98 and $7.44. - Stock Titan
A cash dividend lowered the exercise prices of options awarded to Kamada (KMDA) counsel Nir Livneh. - Stock Titan
Kamada (KMDA) VP’s option prices were adjusted for a special dividend: $5.98 and $7.44 a share. - Stock Titan
Options for Kamada (KMDA) director Leon Recanati vest 25% a year and expire after 10 years. - Stock Titan
A special dividend changed the exercise prices on Kamada (KMDA) CFO's stock options. - Stock Titan
Dividend-linked option reset for Kamada (KMDA) VP - Stock Titan
Kamada (KMDA) director reports 46,000 options at $6.10–$7.38 - Stock Titan
Kamada (NASDAQ: KMDA) grants director 46,000 options; exercise prices adjusted for dividend - Stock Titan
Stock options for Kamada (NASDAQ: KMDA) VP priced at $5.98 and $7.44 - Stock Titan
Special-dividend-adjusted options for Kamada (KMDA) VP - Stock Titan
Kamada (NASDAQ: KMDA) grants director 37,500 share options - Stock Titan
Three option awards for a Kamada (KMDA) director carry prices from $5.99 to $7.41 per share. - Stock Titan
Kamada Ltd. stock holds gains after recent move in healthcare sector - AD HOC NEWS
Kamada Stock Price Forecast. Should You Buy KMDA? - StockInvest.us
StoneX reiterates Kamada stock buy rating on rabies treatment supply By Investing.com - Investing.com Nigeria
Kamada Ltd. (KMDA) Stock Analysis: A Healthcare Gem With 55.71% Potential Upside - DirectorsTalk Interviews
Kamada Ltd (KMDA) Director David Tsur Sells 22,827 Shares - GuruFocus
Kamada Ltd Director David Tsur Sells 22,827 Shares in September 2026 Transaction - Kalkine Media
Kamada (NASDAQ: KMDA) VP exercises options, uses 7,395 shares to cover costs - Stock Titan
Net option move leaves Kamada (KMDA) legal chief 3,459 shares - Stock Titan
5.30%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):